Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
企業コードPFE
会社名Pfizer Inc
上場日Feb 22, 2080
最高経営責任者「CEO」Bourla (Albert)
従業員数81000
証券種類Ordinary Share
決算期末Feb 22
本社所在地66 Hudson Boulevard East
都市NEW YORK
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号10001-2192
電話番号12127332323
ウェブサイトhttps://www.pfizer.com/
企業コードPFE
上場日Feb 22, 2080
最高経営責任者「CEO」Bourla (Albert)